Benefit–risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials

B. E. Strober, A. B. Gottlieb, P. C.M. van de Kerkhof, L. Puig, H. Bachelez, E. Chouela, S. Imafuku, D. Thaçi, H. Tan, H. Valdez, P. Gupta, M. Kaur, V. Frajzyngier, R. Wolk

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Benefit–risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences